According to the announcement the Turner Spectrum Fund will seek to capture alpha, reduce volatility, and preserve capital in declining markets by investing in the following long/short strategies, each managed by a separate portfolio management team at Turner:
- Turner Market Neutral strategy, directed by Robert E. Turner, lead portfolio manager, investing in stocks in all stock market sectors, with a typical allocation resulting in a market-neutral net exposure;
- Turner Long/Short Equity strategy, directed by Christopher K. McHugh, lead portfolio manager, investing in stocks in all stock-market sectors, with a focus on mid-sized and large companies globally;
- Turner Select Opportunities strategy, directed by Frank L. Sustersic, lead portfolio manager, investing primarily in small-cap stocks across all sectors;
- Turner Global Medical Sciences strategy, directed by Vijay Shankaran, lead portfolio manager, investing primarily in health-care stocks in global markets;
- Turner Global Financial Services strategy, directed by David J. Honold Jr., lead portfolio manager, investing primarily in financial stocks in global markets; and
- Turner Global Consumer strategy, directed by Jason D. Schrotberger, lead portfolio manager, investing primarily in consumer-discretionary and consumer-staples stocks in global markets.
Although each strategy’s weighting in the fund will vary as a result of performance, Turner intends to rebalance each weighting equally at the end of every year, the announcement said.
The Institutional Class Shares (TSPEX) of the Turner Spectrum Fund will require a minimum initial investment of $100,000, with an expense ratio initially capped at 1.95%. The Investor Class Shares (TSPCX) will be available with a minimum initial investment of $2,500 and an expense ratio initially capped at 2.20%.
The Turner Spectrum Fund will not charge investors a performance fee.
More information is at www.turnerinvestments.com .
« ING Announces Intent to be 403(b) Prototype Plan Provider